Dystrophic pathways in human hair follicles after chemotherapy with or without scalp cooling

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON27897

Enrollment

Registered

2016-11-03

Start date

2017-03-16

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chemotherapy, Scalp Cooling, Alopecia, Dystrophic Pathway, Hair follicle Chemotherapie, hoofdhuidkoeling, alopecia, dystrofisch signaalpad, haar follikel

Interventions

Why scalp cooling is effective in one patient but not in another remains unclear. As the rationale for the use of scalp hypothermia has not been completely elucidated, the cooling protocol may not be

Eligibility

Inclusion criteria

Inclusion criteria: - Patients with cancer - Indication for at least one cycle docetaxel or paclitaxel - Age 18 years or more - Written informed consent

Exclusion criteria

Exclusion criteria: - Not applicable

Design outcomes

Primary

Measure	Time frame
Expression of damage-response pathways	—

Contacts

Public ContactM.M.C. Komen

Wilhelminalaan 12

manon.komen@mca.nl+31 (0)72 5482872

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)